Estimation of Percentage of Patients With Fibroblast Growth Factor Receptor Alterations Eligible for Off-label Use of Erdafitinib

Lelia Maria de Almeida Carvalho, Sandra de Oliveira Sapori Avelar, Alyson Haslam, Jennifer Gill, Vinay Prasad

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Estimation of Percentage of Patients With Fibroblast Growth Factor Receptor Alterations Eligible for Off-label Use of Erdafitinib'. Together they form a unique fingerprint.

Medicine & Life Sciences